2024 ESMO Annual Meeting Insights Hub
Avatar

ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials

By 2024 ESMO Annual Meeting Insights Hub FEATURING Douglas Johnson
By 2024 ESMO Annual Meeting Insights Hub FEATURING Douglas Johnson
18 views
September 25, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
20:09
Scripps Health

Dysplastic Nevi: Navigating the Risk Landscape

Feat. B. Kelley
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
35:23
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

Feat. S. Patel
09:00
AAD 2024

AAD 2024 Insights: What's New In Nail Tumors

Feat. J. Dominguez-Cherit
10:01
AAD 2024

AAD 2024 Insights: The Latest Advances in the Treatment of Melanoma

Feat. V. Sondak
27:38
Oncology Data Advisor

Sun Safety and Melanoma Awareness: Expert Tips on Preventing Sun Dam…

Feat. T. Knight, M. Hadfield
11:05
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, …

Feat. D. Johnson
09:26
Oncology Data Advisor

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Feat. M. Hadfield
22:58
Tarek Haykal

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

25:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Insights in Melanoma"

Feat. O. Hamid
09:54
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Ou…

Feat. H. Tawbi
18:28
Vanderbilt University Medical Center (VUMC)

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Feat. D. Johnson
03:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib …

Feat. A. Hauschild
24:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and A…

Feat. Z. Eroglu
14:42
Jeff Yorio

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

55:10
University of Colorado Cancer Center

History of Cancer and Its Treatment: What Will It Take to Cure?

Feat. C. Lieu
08:41
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in …

Feat. C. Blank
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde